Ligand validation:6D61

TRS: 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6D61_TRS_A_204	60%	41%	0.104	0.887	1.18	1.1	-	1	0	0	100%	1
6BVQ_TRS_A_204	74%	65%	0.121	0.952	0.5	0.85	-	-	0	0	100%	1
6D60_TRS_A_203	73%	41%	0.106	0.934	1.23	1.08	-	-	0	0	100%	1
6X11_TRS_A_201	73%	86%	0.1	0.926	0.2	0.5	-	-	0	0	100%	1
6BVR_TRS_A_201	73%	73%	0.108	0.933	0.43	0.6	-	-	0	0	100%	1
6D62_TRS_A_204	70%	39%	0.098	0.913	1.25	1.13	-	1	0	0	100%	1
8Z2Q_TRS_B_604	100%	62%	0.017	0.998	0.38	1.06	-	-	1	0	100%	1
8Z2S_TRS_A_603	100%	74%	0.023	0.993	0.3	0.7	-	-	0	0	100%	1
2YZJ_TRS_A_6646	100%	78%	0.031	0.99	0.56	0.34	-	-	1	0	100%	1
4RT5_TRS_A_203	100%	58%	0.039	0.992	0.67	0.93	-	-	1	0	100%	1
1FHF_TRS_B_4001	100%	21%	0.034	0.986	1.79	1.55	1	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.